≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Other and unspecified aplastic anaemias

DOID EFO Endpoint Browser PheWeb

D3_OTHERAPLASTICANAEMIA

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D61
  • Hospital discharge: ICD-9 — 2848
  • Hospital discharge: ICD-8 — 284
  • Hospital discharge: excluded ICD-9 — 2848C
  • Hospital discharge: excluded ICD-8 — 28404
  • Cause of death: ICD-10 — D61
  • Cause of death: ICD-9 — 2848
  • Cause of death: ICD-8 — 284
  • Cause of death: excluded ICD-9 — 2848C
  • Cause of death: excluded ICD-8 — 28404
  • KELA reimbursements: KELA codes — 122

3 out of 7 registries used, show all original rules.

395

4. Check minimum number of events

None

395

5. Include endpoints

None

395

6. Filter based on genotype QC (FinnGen only)

395

Control definitions (FinnGen only)

Control exclude
D3_APLASTICANDOTHANAEMIA

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D60-D64
Name in latin
Aliae anaemia aplasticae

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 4109 2037 1985
Only index persons 2722 1371 1351
Unadjusted period prevalence (%)
Whole population 0.06 0.06 0.06
Only index persons 0.05 0.05 0.05
Median age at first event (years)
Whole population 64.32 65.00 63.49
Only index persons 61.52 61.81 61.22

-FinnGen-

Key figures

All Female Male
Number of individuals 395 192 203
Unadjusted period prevalence (%) 0.08 0.07 0.09
Median age at first event (years) 60.46 54.48 66.11

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
374
Matched controls
3740
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D61.9
ICD-10 Finland
Aplastic anaemia, unspecified
+∞
195.4
170
*
D64.9
ICD-10 Finland
Anaemia, unspecified
49.9
126.5
153
51
XW000
NOMESCO Finland
Bone marrow biopsy
36.4
105.9
138
59
122
Kela drug reimbursment
Aplastic anaemia
+∞
101.8
93
*
WW500
NOMESCO Finland
Blood transfusion
30.7
79.0
107
48
D61.0
ICD-10 Finland
Constitutional aplastic anaemia
+∞
70.0
65
*
D61.3
ICD-10 Finland
Idiopathic aplastic anaemia
+∞
60.0
56
*
L04AD01
ATC
ciclosporin; systemic
37.4
57.2
73
24
D61.1
ICD-10 Finland
Drug-induced aplastic anaemia
+∞
55.6
52
*
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
45.1
52.4
64
17
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
112.3
46.0
49
5
D70.89
ICD-10 Finland
Neutropenic splenomegaly
70.9
39.0
44
7
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
11.5
35.7
69
72
L03AA02
ATC
filgrastim; parenteral
16.2
31.2
51
36
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.8
28.9
109
292
D61.8
ICD-10 Finland
Other specified aplastic anaemias
+∞
28.5
27
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.7
27.4
158
619
ZX120
NOMESCO Finland
Intravenous
5.8
26.2
81
171
R50.9
ICD-10 Finland
Fever, unspecified
4.6
26.0
103
286
H02AB06
ATC
prednisolone; systemic
3.2
25.6
222
1167
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.2
25.6
215
1104
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
7.5
25.2
62
96
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
12.6
24.9
45
40
L04AA01
ATC
[U] ciclosporin; systemic
15.5
23.2
38
27
B03XA02
ATC
darbepoetin alfa; parenteral
22.5
23.0
33
16
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
51.0
20.4
24
5
D61.2
ICD-10 Finland
Aplastic anaemia due to other external agents
+∞
20.0
19
*
127
Kela drug reimbursment
Transplant complication
19.0
19.9
30
17
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
58.2
19.1
22
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
20.0
18.9
28
15
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
44.2
17.5
21
5
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
44.2
17.5
21
5
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.4
16.7
91
322
A04AA01
ATC
ondansetron; systemic, rectal
5.8
16.6
48
92
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
25.8
16.2
22
9
J01MA12
ATC
levofloxacin; systemic
3.1
16.2
103
407
TPH04
NOMESCO Finland
Cathetrisation of vein
3.0
16.0
109
451
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.8
15.6
72
223
JN4BD
NOMESCO Finland
Extensive body CT
3.8
15.3
70
215
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
59.1
14.9
17
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
5.1
14.6
47
102
A41.9
ICD-10 Finland
Sepsis, unspecified
7.0
14.6
36
56
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
7.0
14.6
36
56
C03CA01
ATC
furosemide; systemic
2.5
14.4
144
739
WW200
NOMESCO Finland
Immunization
8.6
14.4
31
39
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.3
13.9
53
137
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.5
13.9
150
800
D70.82
ICD-10 Finland
Drug-induced neutropenia
14.3
13.9
23
17
D60.9
ICD-10 Finland
Acquired pure red cell aplasia, unspecified
+∞
13.6
13
*
B02BX05
ATC
eltrombopag; oral
144.9
13.5
14
*
A05AA02
ATC
ursodeoxycholic acid; oral
12.9
12.8
22
18
A02BC02
ATC
pantoprazole; systemic
2.3
12.7
247
1723
H02AB09
ATC
hydrocortisone; systemic
8.5
12.6
27
34
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
4.9
12.4
41
92
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
7.8
11.9
27
37
ZX108
NOMESCO Finland
Inhalation
17.7
11.3
17
10
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
14.5
11.1
18
13
L04AA06
ATC
mycophenolic acid; systemic
12.4
11.0
19
16
L04AX01
ATC
azathioprine; systemic
5.1
10.9
34
72
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.3
10.7
116
605
3039
Kela drug reimbursment
NA
113.0
10.5
11
*
1517
Kela drug reimbursment
NA
113.0
10.5
11
*
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
9.2
10.4
21
24
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
33.5
10.4
13
*
N02AA05
ATC
oxycodone; systemic
2.7
10.4
76
321
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.0
10.0
194
1294
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
12.6
9.9
17
14
TK800
NOMESCO Finland
Hemodialysis
9.1
9.9
20
23
J05AB11
ATC
valaciclovir; oral
2.9
9.8
61
233
D64.8
ICD-10 Finland
Other specified anaemias
15.5
9.6
15
10
Z51.5
ICD-10 Finland
Palliative care
4.1
9.5
37
98
D59.5
ICD-10 Finland
Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]
+∞
9.4
9
*
JMA11
NOMESCO Finland
Laparoscopic total splenectomy
+∞
9.4
9
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
6.7
9.4
23
36
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.6
9.4
76
339
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
6.3
9.4
24
40
UJF32
NOMESCO Finland
Coloscopy
2.2
9.3
110
590
B03BA03
ATC
hydroxocobalamin; parenteral
4.0
9.2
37
101
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
37.6
9.1
11
*
N17.9
ICD-10 Finland
Acute renal failure, unspecified
5.0
9.1
28
59
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.1
8.9
49
171
A46
ICD-10 Finland
Erysipelas
2.6
8.8
68
295
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
4.5
8.7
30
71
Z3231
NOMESCO Finland
Registered nurse
2.1
8.7
118
671
J02AC03
ATC
voriconazole; systemic
92.0
8.4
9
*
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
92.0
8.4
9
*
Z49.1
ICD-10 Finland
Extracorporeal dialysis
13.2
8.4
14
11
M04AA01
ATC
allopurinol; systemic
2.6
8.4
67
294
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
3.4
8.4
40
127
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
+∞
8.4
8
*
28409
ICD-8 Finland
Aplastic anaemia, Unspecified
+∞
8.4
8
*
V03AC03
ATC
deferasirox; oral
+∞
8.4
8
*
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
7.8
8.3
18
24
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.0
8.1
47
172
XF400
NOMESCO Finland
ECG with 12 standard connections
2.3
8.0
77
373
L03AA13
ATC
pegfilgrastim; parenteral
5.9
7.9
21
37
H02AB07
ATC
prednisone; oral
2.5
7.9
62
271
R18
ICD-10 Finland
Ascites
8.7
7.9
16
19
J01MA14
ATC
moxifloxacin; systemic
3.1
7.7
43
151
WX892
NOMESCO Finland
Monitored bed care
3.1
7.7
43
151
A03FA01
ATC
metoclopramide; systemic, rectal
2.3
7.7
81
408
J05AB01
ATC
aciclovir; systemic
2.2
7.5
84
437
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
6.7
7.5
18
28
D69.5
ICD-10 Finland
Secondary thrombocytopenia
81.6
7.4
8
*
D69.1
ICD-10 Finland
Qualitative platelet defects
81.6
7.4
8
*
Z31.5
ICD-10 Finland
Genetic counselling
4.5
7.4
25
59
B03XA01
ATC
erythropoietin; parenteral
11.2
7.3
13
12
175
Kela drug reimbursment
Deferasirox
+∞
7.3
7
*
JN4AD
NOMESCO Finland
Body CT examination
3.3
7.3
36
118
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
16.1
7.3
11
7
H02AB04
ATC
methylprednisolone; systemic
2.4
7.2
61
277
TGC00
NOMESCO Finland
Bronchial lavation
5.2
7.2
21
42
SPAT1088
SPAT
Blood transfusion
30.6
7.2
9
*
D51.0
ICD-10 Finland
Vitamin B12deficiency anaemia due to intrinsic factor deficiency
30.6
7.2
9
*
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
20.5
7.2
10
5
C90.0
ICD-10 Finland
Multiple myeloma
12.3
7.1
12
10
N02AX02
ATC
tramadol; systemic, rectal
1.8
7.0
156
1049
ZXD05
NOMESCO Finland
Urgent procedure
1.9
7.0
126
792
B02AA02
ATC
tranexamic acid; systemic
2.5
6.9
54
236
H02AB02
ATC
dexamethasone; systemic
2.7
6.9
45
178
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.3
6.8
33
107
D62
ICD-10 Finland
Acute posthaemorrhagic anaemia
40.8
6.8
8
*
AA1AD
NOMESCO Finland
CT of head and brain
2.0
6.7
95
544
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
8.9
6.6
13
15
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.0
6.5
85
471
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
4.1
6.5
24
62
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.6
6.5
28
83
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
8.4
6.4
13
16
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
5.7
6.4
17
31
A11CC03
ATC
alfacalcidol; systemic
5.7
6.4
17
31
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
6.1
6.4
16
27
D46.2
ICD-10 Finland
Refractory anaemia with excess of blasts [RAEB]
+∞
6.3
6
*
2848X
ICD-9 Finland
Aplastic anaemia, Other specified aplastic anaemias[ANAEMIA APLASTICA ACQUISITA NON DEFINITA]
+∞
6.3
6
*
28402
ICD-8 Finland
Aplastic anaemia, Acquisita secundaria
+∞
6.3
6
*
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
27.1
6.2
8
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.5
6.2
49
213
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.6
6.1
44
184
L01BB02
ATC
mercaptopurine; oral
8.8
6.1
12
14
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
8.8
6.1
12
14
Z01.8
ICD-10 Finland
Other specified special examinations
2.0
6.1
80
443
B82
ICPC
Anaemia other/unspecified
6.2
6.1
15
25
I50.9
ICD-10 Finland
Heart failure, unspecified
2.2
6.0
62
310

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(21494434) Karyotype in Bone marrow
90
23
50.38
151.37
1.6
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
89
25
45.66
146.02
2.0
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
94
39
31.32
136.56
2.5
1.8
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
198
310
11.80
135.60
11.7
3.7
u/l
253.6
241.2
0.58
188
290
(3027945) Reticulocytes/100 erythrocytes in Blood
198
328
11.10
128.81
11.7
2.5
%
1.9
1.7
1.92
184
294
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
123
104
16.72
128.20
2.6
1.7
g/l
1.2
1.6
2.17
102
89
(3023520) Reticulocytes [#/volume] in Blood
166
238
11.31
120.37
12.1
2.2
e9/l
63.3
67.8
0.65
137
184
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
89
58
19.52
105.88
2.1
1.7
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
76
43
21.65
96.40
6.7
5.1
iu/ml
340.4
832.8
—
9
5
(3011412) CD3 cells [#/volume] in Blood
49
26
21.37
63.26
2.3
1.8
e9/l
1.1
1.2
—
26
10
(3005719) IgG [Mass/volume] in Serum or Plasma
117
231
6.78
60.43
4.0
2.6
g/l
10.1
10.3
0.13
110
213
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
58
48
13.99
59.52
1.4
1.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
56
49
13.15
55.45
1.5
1.4
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
52
41
14.45
54.79
1.7
1.3
u/ml
98.8
84.4
—
9
9
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
37
15
27.11
52.91
2.3
1.9
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
52
48
12.32
49.64
1.5
1.5
u/ml
279.0
233.7
0.29
33
27
(3004789) Transferrin [Mass/volume] in Serum or Plasma
141
396
4.98
48.19
4.1
2.2
g/l
2.0
2.3
6.94
135
362
(3028026) IgM [Mass/volume] in Serum or Plasma
95
192
6.20
47.14
2.3
1.5
g/l
1.5
1.2
0.37
82
178
(3022948) Iron [Moles/volume] in Serum or Plasma
148
440
4.78
46.97
4.2
2.2
umol/l
17.9
13.5
4.57
142
399
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
39
24
17.92
46.71
2.2
1.8
e6/l
414.8
467.1
0.20
29
19
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
135
378
4.91
46.09
4.2
2.2
%
37.4
23.3
6.68
122
327
(42870588) Differential panel, method unspecified - Blood
229
968
4.25
44.65
22.2
5.4
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
35
19
20.11
44.39
1.2
1.2
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
146
449
4.57
44.00
7.8
3.4
mmol/l
0.8
0.8
3.42
138
421
(3020630) Protein [Mass/volume] in Serum or Plasma
100
230
5.48
42.86
3.0
2.7
g/l
64.8
66.6
1.33
92
208
(3004588) Protein electrophoresis panel - Serum or Plasma
89
187
5.85
42.11
1.7
2.6
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
63
98
7.46
40.05
1.5
1.4
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
184
721
3.91
38.80
3.2
2.0
mg/l
3.2
3.0
0.46
156
618
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
34
23
16.08
38.68
1.3
1.5
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
56
82
7.79
37.49
1.8
4.0
mg/l
46.5
138.5
0.58
43
63
(3021879) Hepatitis B virus core Ab [Presence] in Serum
89
207
5.26
37.35
1.6
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
27
12
24.08
37.03
2.1
2.0
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
27
12
24.08
37.03
2.1
2.0
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
264
1351
3.88
36.46
21.8
5.6
%
0.6
0.6
1.19
255
1265
(3019069) Monocytes/100 leukocytes in Blood
269
1397
3.90
36.25
23.3
5.8
%
9.4
8.6
2.75
262
1313
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
55
82
7.63
36.21
1.8
4.0
mg/l
36.0
31.5
0.28
42
64
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
34
26
14.21
36.13
2.6
2.9
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
267
1385
3.86
35.92
22.2
5.5
%
2.4
2.8
1.80
259
1293
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
40
41
10.74
35.34
1.2
1.0
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
275
1475
3.85
34.68
20.6
5.4
e9/l
0.5
0.6
7.00
255
1285
(3002030) Lymphocytes/100 leukocytes in Blood
270
1434
3.79
34.51
22.6
5.6
%
34.0
27.6
7.80
262
1343
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
33
26
13.76
34.44
2.3
2.1
e6/l
524.9
594.9
0.17
14
11
(3006315) Basophils [#/volume] in Blood
275
1480
3.82
34.38
20.7
5.4
e9/l
0.0
0.0
6.69
254
1295
(3018010) Neutrophils/100 leukocytes in Blood
265
1416
3.65
32.98
21.3
5.4
%
50.1
57.4
10.57
257
1330
(3026493) Urate [Moles/volume] in Serum or Plasma
176
730
3.54
32.97
5.3
2.8
umol/l
1989.8
8655.5
1.81
160
618
(3013115) Eosinophils [#/volume] in Blood
277
1526
3.73
32.76
23.2
5.8
e9/l
0.1
0.2
8.15
257
1348
(40760888) Immunoglobulin light chains.free panel - Serum
44
57
8.56
32.55
1.7
4.5
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
275
1519
3.67
32.14
20.9
5.5
e9/l
1.8
2.0
0.49
256
1351
(3017143) Hepatitis C virus Ab [Presence] in Serum
110
339
4.11
31.96
1.8
1.4
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
110
341
4.08
31.68
6.0
2.9
umol/l
10.2
8.8
0.17
97
300
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
270
1538
3.39
28.66
17.5
5.7
umol/l
12.9
11.9
0.60
264
1450
(4035726)
86
240
4.30
28.34
1.7
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
36
44
8.90
27.81
1.1
1.1
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
287
1729
3.41
27.05
35.1
8.4
e9/l
3.2
4.2
3.78
272
1518
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
32
35
9.86
26.85
9.5
1.9
pg
35.8
33.8
1.89
32
35
(3000060) B lymphocytes [#/volume] in Blood
21
11
20.11
26.73
2.3
2.2
e6/l
121.0
303.3
—
10
6
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
33
9
39.81
26.59
1.2
1.2
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
86
253
4.07
26.27
2.8
2.6
g/l
0.2
0.2
0.29
78
232
(3017181) Myelocytes/100 leukocytes in Blood
83
241
4.09
25.79
9.9
4.2
%
1.1
1.1
0.05
53
78
(3019309) Folate [Moles/volume] in Red Blood Cells
138
560
3.25
25.72
2.1
1.7
nmol/l
1248.0
1158.2
0.45
118
418
(3001122) Ferritin [Mass/volume] in Serum or Plasma
235
1288
3.04
25.63
6.0
2.6
ug/l
447.9
118.3
8.50
224
1171
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
121
456
3.38
25.44
1.8
1.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
181
866
3.01
25.19
8.6
3.9
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
231
1273
2.96
24.61
10.9
4.4
g/l
34.1
35.4
2.99
223
1184
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
51
104
5.48
24.42
1.5
2.1
g/l
3.2
3.1
0.20
38
79
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
73
201
4.23
24.30
2.7
1.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
37
55
7.32
24.21
1.4
1.9
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
42
74
6.23
23.41
2.5
1.5
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
29
8
38.94
23.33
1.2
1.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
21
15
14.73
22.95
1.4
1.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
52
114
5.10
22.92
1.5
2.0
g/l
7.0
7.3
0.44
38
81
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
52
114
5.10
22.92
1.5
2.0
g/l
4.0
3.7
0.55
38
77
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
52
114
5.10
22.92
1.5
2.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
35
52
7.29
22.89
2.5
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
41
73
6.15
22.60
2.8
1.5
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
29
35
8.86
22.54
6.0
4.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
25
26
10.20
21.66
1.1
1.0
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
48
104
5.12
21.41
1.6
2.1
g/l
10.2
10.1
0.03
39
89
(46235355) HIV 1 and 2 tests - Meaningful Use set
131
567
2.96
21.25
2.0
1.8
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
186
973
2.72
20.94
13.8
2.4
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
45
95
5.22
20.66
1.6
2.4
g/l
0.6
0.7
0.17
39
82
(3002179) Metamyelocytes/100 leukocytes in Blood
71
215
3.81
20.55
10.2
4.1
%
0.7
0.4
0.73
44
52
(3025159) Blasts/100 leukocytes in Blood
69
209
3.79
19.94
10.7
4.4
%
0.3
0.2
0.23
46
57
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
243
1484
2.66
19.53
16.7
6.5
mmol/l
1.2
1.2
1.30
211
1252
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
41
85
5.27
19.18
2.0
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
71
226
3.61
19.03
10.1
4.3
%
0.1
0.1
0.16
49
68
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
28
40
7.46
18.90
2.1
1.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
119
518
2.86
18.80
3.4
1.7
—
—
—
0
0
(40758558) Short blood count panel - Blood
153
759
2.66
18.72
26.5
6.3
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
17
12
14.76
18.59
2.3
3.6
u/ml
1153.2
670.0
0.57
17
12
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
151
748
2.65
18.49
13.6
2.2
—
—
—
0
0
(3048879) Bone marrow aspiration report
22
5
46.39
18.43
2.2
3.8
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
206
1195
2.51
17.95
3.0
1.9
pmol/l
89.0
93.4
0.67
139
622
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
136
649
2.67
17.85
2.9
1.7
mg/l
1.3
1.2
0.37
105
493
(3018418) pH of Serum or Plasma
169
898
2.54
17.73
10.0
3.6
ph
7.4
7.4
0.07
30
159
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
23
28
8.66
17.68
2.0
1.4
—
—
—
0
0
(3024471) HLA-A [Type]
21
5
44.15
17.45
1.0
1.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
129
615
2.63
16.82
2.1
1.4
g/l
2.3
2.4
0.13
98
374
(3037522) Nuclear Ab [Titer] in Serum
93
376
2.93
16.65
1.5
1.4
titre
394.3
474.2
0.15
14
89
(3024932) HLA-DR beta [Type]
20
5
42.03
16.48
1.4
1.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
142
716
2.54
16.42
2.4
1.5
nmol/l
19.5
20.8
0.56
129
592
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
90
360
2.94
16.41
3.0
1.6
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
172
957
2.41
15.93
6.1
3.0
u/l
32.6
31.9
0.13
160
911
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
36
79
4.91
15.74
1.4
1.2
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
220
1374
2.36
15.50
15.4
5.9
mmol/l
1.2
1.2
1.84
210
1225
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
222
1402
2.33
15.11
21.4
4.0
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
21
28
7.86
14.97
6.7
2.9
%
39.1
59.0
1.98
15
18
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
26
45
6.11
14.65
8.7
3.7
%
47.2
58.4
1.96
26
45
(3032080) INR in Blood by Coagulation assay
200
1223
2.29
14.51
10.7
9.6
inr
1.4
1.3
0.21
61
353
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
55
176
3.47
14.48
2.6
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
87
365
2.77
14.38
3.1
1.7
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
14
11
13.16
14.32
2.4
1.7
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
212
1342
2.25
13.97
29.5
8.9
e9/l
0.1
0.0
0.49
189
1102
(3030905) Polymorphonuclear cells [#/volume] in Blood
25
44
6.00
13.85
5.8
3.3
e9/l
2.4
4.3
3.74
25
44
(3000012) Reticulocyte production index
17
20
8.84
13.34
2.9
1.7
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
23
39
6.20
13.21
2.7
1.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
26
50
5.50
13.14
1.2
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
26
50
5.50
13.14
2.1
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
36
93
4.16
12.84
2.9
2.1
u/ml
0.3
0.3
0.29
13
52
(40760892) CBC W Ordered Manual Differential panel - Blood
123
642
2.33
12.66
13.9
4.7
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
23
41
5.89
12.57
2.7
1.7
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
22
39
5.91
12.08
2.0
1.5
—
—
—
0
0
(44790049)
22
39
5.91
12.08
2.6
1.4
—
—
—
0
0
(44790048)
22
39
5.91
12.08
2.6
1.4
—
—
—
0
0
(44806118)
22
39
5.91
12.08
2.6
1.4
—
—
—
0
0
(44790047)
22
39
5.91
12.08
2.6
1.4
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
15
17
9.13
12.07
1.7
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
15
17
9.13
12.07
1.7
1.2
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
13
12
11.17
12.02
5.1
1.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
18
26
7.21
11.95
1.7
1.1
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
68
279
2.74
11.59
2.7
1.9
nmol/l
356.0
381.7
0.49
62
257
(3052851) Hemolysis interference index of Serum or Plasma
33
87
4.05
11.45
4.8
2.8
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
13
13
10.31
11.39
1.7
1.1
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
13
13
10.31
11.39
1.7
1.1
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
250
1775
2.11
11.34
10.8
4.7
mmol/l
6.7
6.6
0.06
244
1642
(3030467) Casts [#/volume] in Urine by Automated count
147
872
2.09
10.71
5.2
3.1
e6/l
0.5
0.4
0.22
119
649
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
174
1105
2.03
10.46
5.7
3.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
22
45
5.12
10.38
2.0
1.5
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
17
27
6.53
10.35
1.6
1.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
142
843
2.07
10.23
5.2
3.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
20
38
5.49
10.22
2.0
1.6
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
156
966
2.02
9.95
5.2
3.2
e6/l
121.1
69.3
0.25
127
739
(3042936) Bacteria identified in Isolate by Culture
88
438
2.30
9.86
2.6
1.9
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
13
16
8.37
9.79
1.5
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
17
29
6.08
9.67
1.2
1.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
49
186
2.87
9.61
1.7
1.3
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
11
11
10.26
9.58
1.2
1.0
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
32
94
3.62
9.54
3.4
3.0
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
295
2301
2.11
9.51
23.6
6.8
u/l
89.4
78.4
1.72
289
2138
(3015377) Calcium [Moles/volume] in Serum or Plasma
158
997
1.97
9.45
5.3
3.0
mmol/l
2.3
2.4
1.24
144
862
(40758292) HTLV I+II Ab panel - Serum
13
6
22.33
9.41
1.5
1.5
—
—
—
0
0
(3000991) Gas panel - Venous blood
59
253
2.57
9.14
19.2
7.6
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
171
1119
1.93
9.10
6.3
3.7
e6/l
61.4
75.2
0.28
132
786
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
177
1172
1.92
9.09
3.4
2.3
nmol/l
72.1
76.2
1.20
166
1029
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
29
83
3.69
8.97
1.1
1.2
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
12
5
24.68
8.96
1.2
1.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
14
21
6.87
8.95
6.1
2.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
77
379
2.28
8.80
2.4
1.6
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
14
23
6.27
8.23
4.9
4.3
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
12
7
17.63
8.12
1.1
1.7
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
68
330
2.28
8.00
9.8
8.0
mmol/l
-0.4
1.3
1.62
56
260
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
29
90
3.40
7.97
1.6
1.6
iu/ml
0.0
0.2
—
5
18
(3000570) Elastase.pancreatic [Mass/mass] in Stool
27
81
3.50
7.81
1.3
1.4
ug/g
234.5
325.7
1.13
18
46
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
94
527
2.03
7.63
4.7
2.7
e6/l
0.7
1.1
1.07
60
301
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
10
12
8.52
7.61
3.0
1.8
umol/l
24.1
28.3
—
10
12
(3037692) Legionella sp identified in Specimen by Organism specific culture
11
15
7.51
7.59
1.2
1.1
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
111
668
1.92
7.32
3.6
2.6
e6/l
5.0
4.8
0.04
102
582
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
37
140
2.81
7.29
9.5
12.0
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
89
498
2.02
7.24
4.8
2.9
e6/l
1.6
1.9
0.27
54
273
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
11
16
7.04
7.18
1.6
1.5
—
—
—
0
0
(3026782) Osmolality of Urine
105
624
1.93
7.17
3.8
2.7
mosm/kgh2o
532.7
573.6
1.01
95
525
(3017732) Neutrophils [#/volume] in Blood
46
200
2.47
6.90
4.5
2.8
e9/l
3.7
3.8
0.08
35
155
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
29
99
3.08
6.85
1.3
1.6
—
266.7
—
0
6
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
16
36
4.59
6.77
3.1
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
16
36
4.59
6.77
3.1
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
16
36
4.59
6.77
3.1
1.6
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
139
928
1.77
6.44
4.4
2.5
u/l
53.5
56.7
0.50
131
861
(3002032) Base excess in Venous blood by calculation
59
295
2.18
6.42
13.5
4.0
mmol/l
1.9
1.9
0.00
51
220
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
10
15
6.81
6.34
1.5
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
97
584
1.88
6.29
4.4
3.6
ng/l
1926.2
246.3
0.50
90
453
(3014148) Varicella zoster virus Ab [Titer] in Serum
14
30
4.80
6.26
1.1
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
21
62
3.52
6.23
1.7
1.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
67
359
2.04
6.08
2.2
1.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
14
31
4.65
6.03
1.1
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
14
31
4.65
6.03
6.3
2.4
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
13
27
4.94
6.01
1.6
2.6
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
13
27
4.94
6.01
1.0
1.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
95
580
1.84
5.86
4.3
2.9
mmol/l
2.5
2.5
0.06
86
506
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
31
121
2.70
5.78
3.9
1.9
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
21
66
3.30
5.68
1.6
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
97
602
1.81
5.66
2.0
1.7
pmol/l
444.4
439.8
0.05
84
492
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
29
112
2.72
5.52
3.0
1.7
—
—
—
0
0
(3019060) Gas panel - Arterial blood
42
194
2.30
5.52
2.9
6.5
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
134
920
1.69
5.46
4.2
3.0
ng/l
3104.8
1418.4
2.07
119
775
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
8
5
16.28
5.43
1.1
3.2
%
182.6
132.8
—
8
5
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
12
26
4.73
5.29
3.2
2.0
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
133
923
1.66
5.15
2.3
2.0
u/l
704.0
303.1
0.33
125
862
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
35
155
2.38
5.06
2.5
2.4
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
9
9
10.20
5.05
1.9
1.8
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
9
9
10.20
5.05
1.3
2.3
%
183.7
99.8
—
9
9
(3031040) Bacteria [#/volume] in Urine by Automated count
248
2018
1.62
4.93
7.1
4.5
e6/l
34.2
2751.7
—
5
40
(3037467) Urinalysis macro (dipstick) panel - Urine
257
2116
1.61
4.81
7.3
4.2
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
10
20
5.10
4.80
3.2
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
10
20
5.10
4.80
3.2
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
10
20
5.10
4.80
3.2
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
10
20
5.10
4.80
3.2
1.7
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
54
294
1.97
4.67
4.8
3.4
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
266
2223
1.60
4.54
7.1
3.9
mm/h
23.0
11.8
10.94
254
2028
(3024980) IgG subclass 4 [Mass/volume] in Serum
16
49
3.36
4.52
1.3
1.4
g/l
0.5
0.6
—
10
42
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
19
67
2.93
4.28
1.7
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
19
67
2.93
4.28
1.7
1.4
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
12
32
3.84
4.11
1.4
1.3
g/l
3.6
2.2
—
6
25
(3024139) IgG subclass 3 [Mass/volume] in Serum
12
32
3.84
4.11
1.4
1.3
g/l
0.3
0.3
—
6
26
(3027135) IgG subclass 1 [Mass/volume] in Serum
12
32
3.84
4.11
1.4
1.3
g/l
7.9
6.2
—
6
26
(3044007) Cell count panel - Peritoneal fluid
7
7
10.15
4.02
2.0
1.7
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
11
28
4.01
4.00
1.2
1.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
17
60
2.92
3.84
12.4
4.6
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
15
6.11
3.83
1.4
1.5
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
23
96
2.48
3.80
1.1
1.3
miu/ml
119.0
335.4
—
6
42
(4062490)
12
34
3.61
3.79
1.4
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
10
25
4.08
3.72
1.0
1.4
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
10
25
4.08
3.72
1.3
2.8
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
8
12
6.78
3.69
1.5
1.5
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
9
16
5.73
3.68
1.2
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
113
811
1.55
3.62
1.8
1.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
97
674
1.58
3.58
5.3
3.7
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
66
416
1.70
3.57
28.0
24.5
inr
1.2
1.4
—
7
59
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
9
7.89
3.57
1.0
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
7
9
7.89
3.57
1.3
1.9
—
—
—
0
0
(3022145) Colonoscopy Study observation
53
314
1.79
3.55
1.8
1.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
17
63
2.77
3.53
2.7
1.4
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
9
17
5.39
3.53
3.4
1.7
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
9
17
5.39
3.53
3.4
1.7
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
8
13
6.26
3.51
1.5
1.5
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
11
31
3.62
3.50
1.5
1.6
mosm/kgh2o
273.9
286.6
0.80
11
22
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
42
232
1.91
3.50
5.1
2.8
ml/min/173m2
61.8
63.2
0.08
21
96
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
69
444
1.67
3.46
1.3
1.2
u/ml
4.2
11.4
0.98
17
174
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
9
18
5.09
3.39
3.4
1.7
—
—
—
0
0
(3034426) Prothrombin time (PT)
7
10
7.10
3.37
1.0
1.5
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
8
14
5.81
3.35
1.1
3.8
%
95.8
94.5
—
8
14
(40768797) Stomach Pathology biopsy report
63
400
1.68
3.32
1.4
1.2
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
6
7
8.68
3.27
1.0
1.0
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
6
7
8.68
3.27
1.2
1.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
6
7
8.68
3.27
2.8
1.6
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
152
1182
1.46
3.26
4.6
3.8
ng/l
31.7
42.2
0.86
127
842
(3025468) Yersinia sp identified in Specimen by Organism specific culture
12
38
3.23
3.24
3.2
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
12
38
3.23
3.24
3.2
1.4
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
14
49
2.93
3.22
1.0
1.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
125
940
1.48
3.17
4.9
3.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
69
1000
0.62
3.16
2.9
2.8
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
12
39
3.14
3.11
3.2
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
12
39
3.14
3.11
3.2
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
12
39
3.14
3.11
3.2
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
12
39
3.14
3.11
3.2
1.4
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
10
29
3.51
3.06
1.8
1.4
%
86.8
63.4
—
5
22
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
6
8
7.59
3.06
3.2
8.1
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
6
8
7.59
3.06
1.7
1.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
55
346
1.68
3.00
2.0
1.7
%
1.8
1.4
1.52
46
309
(3048689) Calprotectin [Mass/mass] in Stool
56
355
1.67
2.97
4.1
2.3
ug/g
302.1
112.0
1.08
48
277
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
8
17
4.78
2.93
1.1
1.1
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
23
109
2.18
2.90
1.0
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
7
13
5.46
2.88
1.1
1.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
7
13
5.46
2.88
1.0
1.8
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
6
9
6.75
2.87
1.3
1.1
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
37
210
1.84
2.86
14.8
5.3
mmol/l
2.3
1.7
0.30
28
157
(3019230) Fractional oxyhemoglobin in Venous blood
13
47
2.83
2.84
14.3
4.5
%
61.8
60.4
0.07
13
47
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
18
4.51
2.81
1.0
1.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
43
258
1.75
2.78
3.5
3.0
ng/l
314.6
181.1
0.56
37
229
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
70
477
1.57
2.78
1.3
1.3
iu/ml
44.9
32.3
0.23
23
151
(21494755) Public health laboratory ask at order entry panel
9
230
0.38
2.78
1.2
1.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
12
42
2.92
2.77
1.9
3.3
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
5
6
8.42
2.75
3.0
1.8
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
13
48
2.77
2.74
2.5
2.3
u/ml
15462.8
93.2
0.47
13
43
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
11
37
3.03
2.71
3.3
4.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
30
162
1.92
2.70
15.9
5.5
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
24
120
2.06
2.67
1.5
2.2
u/l
36.7
39.2
0.23
19
110
(3009343) pH of Capillary blood
38
223
1.78
2.65
14.5
5.1
ph
7.4
7.4
—
6
24
(3024891) Influenza virus A+B Ag [Presence] in Specimen
17
74
2.36
2.61
1.5
1.3
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
15
4.73
2.61
1.0
1.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
8
20
4.06
2.58
3.5
2.4
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
43
264
1.71
2.58
2.3
2.4
ug/l
6.9
6.3
0.09
37
231
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
225
1933
1.38
2.55
5.2
3.0
u/l
65.2
47.0
1.68
216
1791
(3006922) Hepatitis E virus Ab [Presence] in Serum
6
11
5.52
2.55
1.0
1.0
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
47
297
1.66
2.53
2.2
4.3
ug/l
4.3
21.6
0.65
38
247
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
18
82
2.25
2.51
2.0
1.5
—
—
—
0
0
(4306422)
11
40
2.80
2.39
1.0
1.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
10
35
2.91
2.32
4.1
3.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
19
93
2.10
2.25
1.9
1.6
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
14
60
2.38
2.24
1.1
1.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
176
1479
1.34
2.19
8.3
4.8
estimate
0.0
0.0
0.00
31
283
(3000475) Leukocytes [#/volume] in Synovial fluid
14
61
2.34
2.17
1.8
1.6
e6/l
10579.4
15901.1
—
7
44
(4268621)
10
37
2.75
2.12
3.1
2.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
45
296
1.59
2.09
1.7
1.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
177
1497
1.33
2.08
5.6
3.6
estimate
0.0
0.0
0.00
32
275
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
10
5.05
2.07
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
10
5.05
2.07
1.0
1.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
22
118
1.92
2.06
2.5
2.5
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
6
15
4.04
2.04
6.7
7.3
%
29.3
40.9
—
6
15
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
6
15
4.04
2.04
5.8
4.2
u/l
200.2
215.9
—
6
15
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
88
669
1.41
2.03
1.4
1.3
u/ml
0.5
1.5
2.03
18
182
(4281824)
8
26
3.12
2.02
1.8
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
39
250
1.62
2.02
5.8
3.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
175
1485
1.32
1.98
5.7
3.5
estimate
0.0
0.0
0.00
33
287
(40768441) Liver Pathology biopsy report
7
21
3.37
1.97
1.1
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
6
16
3.79
1.94
9.7
9.9
%
8.6
12.4
—
6
16
(3035637) Corticotropin [Mass/volume] in Plasma
9
34
2.68
1.87
1.2
1.4
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
6
17
3.57
1.84
1.7
1.5
umol/l
13.6
22.3
—
6
17
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
28
169
1.71
1.82
6.1
3.1
pmol/l
4.6
4.6
0.10
20
150
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
7
23
3.08
1.80
5.0
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
13
60
2.21
1.79
2.4
2.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
11
47
2.38
1.79
1.0
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
11
47
2.38
1.79
2.4
1.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
35
227
1.59
1.75
1.2
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
19
103
1.89
1.75
1.8
1.6
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
18
96
1.92
1.73
2.2
1.6
iu/l
26.0
22.1
0.14
11
80
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
13
61
2.17
1.73
1.2
1.2
—
33.4
—
0
7
(3005322) IgE [Units/volume] in Serum or Plasma
28
173
1.67
1.69
1.9
1.2
u/ml
1082.8
298.7
0.59
23
150
(3045414) Leukocytes [Presence] in Urine
20
112
1.83
1.68
2.1
1.8
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
55
741
0.70
1.67
1.7
1.6
mmol/l
1.4
1.3
0.41
49
612
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
14
3.60
1.62
1.0
1.4
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
7
26
2.72
1.58
1.0
1.0
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
9
37
2.47
1.49
1.0
1.2
nmol/l
0.6
0.5
—
9
32
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
14
73
1.95
1.45
1.9
1.3
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
12
59
2.07
1.45
3.7
2.6
%
11.7
16.1
—
6
33
(3013139) Helicobacter pylori Ag [Presence] in Stool
27
173
1.60
1.44
1.2
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
16
3.15
1.44
1.4
1.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
250
2705
0.79
1.40
6.6
5.7
mmol/mol
39.9
39.8
0.05
231
2499
(3020891) Body temperature
19
112
1.73
1.38
4.6
4.8
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
14
243
0.56
1.32
1.4
1.7
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
25
161
1.59
1.32
2.0
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
100
826
1.28
1.32
4.0
3.2
mg/l
1945.1
300.1
0.91
77
533
(3025130) Human papilloma virus identified in Specimen
8
34
2.38
1.30
1.6
2.0
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
12
62
1.96
1.29
3.3
3.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
35
2.31
1.27
1.0
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
8
35
2.31
1.27
2.0
1.6
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
5
119
0.41
1.26
1.8
1.6
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
6
25
2.42
1.25
1.0
1.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
6
25
2.42
1.25
1.0
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
19
298
0.62
1.23
1.8
1.8
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
19
117
1.66
1.20
4.5
3.2
g/l
0.2
0.2
0.16
13
42
(3044290) Cell count panel - Cerebral spinal fluid
12
64
1.90
1.19
1.0
1.4
—
—
—
0
0
(3019225) pH of Specimen
39
284
1.41
1.18
8.3
4.0
—
—
—
0
0
(3044889) 12 lead EKG panel
224
2046
1.22
1.15
4.3
3.9
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
23
151
1.56
1.14
6.2
3.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
276
2929
0.81
1.13
4.7
4.8
mmol/l
2.5
2.7
2.79
262
2670
(3026389) Candida sp identified in Specimen by Organism specific culture
7
30
2.36
1.13
1.7
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
136
1185
1.23
1.11
2.7
2.0
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
7
31
2.28
1.11
1.3
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
268
2850
0.81
1.10
4.3
4.3
mmol/l
1.4
1.4
2.34
252
2606
(3007461) Platelets [#/volume] in Blood
322
3355
0.78
1.07
73.0
20.3
e9/l
186.9
245.6
20.03
317
3268
(3022806) Fractional oxyhemoglobin in Capillary blood
7
33
2.14
1.06
2.6
1.8
%
92.2
90.6
—
7
33
(3009508) Creatinine [Moles/volume] in Urine
106
905
1.23
1.05
4.1
3.0
mmol/l
6.9
7.7
0.92
94
750
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
271
2873
0.82
1.04
4.3
4.4
mmol/l
4.4
4.6
2.74
260
2637
(3000492) Spirometry study
35
258
1.39
1.01
1.6
1.4
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
7
35
2.02
1.00
2.9
2.8
nmol/l
1.2
3.1
—
7
35
(3010813) Leukocytes [#/volume] in Blood
323
3358
0.79
0.99
72.5
20.3
e9/l
6.0
6.8
2.78
317
3261
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
23
2.19
0.98
1.6
1.7
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
268
2838
0.83
0.98
5.3
4.5
mmol/l
6.1
5.9
0.67
244
2565
(3026361) Erythrocytes [#/volume] in Blood
323
3357
0.79
0.98
72.6
20.3
e12/l
3.8
4.5
48.79
318
3260
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
28
384
0.71
0.97
2.4
2.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
6
117
0.51
0.95
1.3
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
15
93
1.64
0.95
2.5
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
11
62
1.80
0.95
7.6
2.9
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
7
37
1.91
0.94
1.0
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
15
94
1.62
0.92
2.5
1.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
6
29
2.08
0.89
1.0
1.2
nmol/l
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
16
104
1.56
0.86
21.9
5.5
kpa
7.9
8.3
0.54
16
94
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
6
31
1.95
0.84
1.8
1.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
6
32
1.89
0.82
1.0
1.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
6
32
1.89
0.82
1.2
1.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
239
2237
1.17
0.82
4.7
3.7
pmol/l
15.1
14.9
0.50
228
1984
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
24
173
1.41
0.81
1.3
1.3
iu/ml
111.9
125.2
—
7
72
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
14
92
1.54
0.73
2.6
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
5
25
2.01
0.73
1.4
1.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
7
39
1.81
0.73
1.1
1.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
315
3029
1.20
0.73
48.0
14.0
mg/l
22.1
24.6
0.92
292
2416
(3013512) EKG study
98
862
1.18
0.71
4.8
3.9
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
27
348
0.76
0.67
2.2
2.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
8
51
1.58
0.60
1.0
1.5
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
20.5
—
1889.8
—
0
20
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
10.6
—
962.0
—
0
20
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
20
0.00
0.60
0.0
1.1
—
36.5
—
0
10
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
20
0.00
0.60
0.0
1.0
—
460.3
—
0
11
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
20
0.00
0.60
0.0
1.0
—
263.8
—
0
10
(3002256) Pathology report gross observation
44
365
1.23
0.60
1.8
1.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
6
35
1.73
0.58
1.0
1.1
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
14
98
1.44
0.57
3.1
4.0
mmol/l
4.0
4.0
0.01
14
89
(3050129) First trimester maternal screen panel - Serum or Plasma
5
90
0.55
0.56
1.0
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
307
3162
0.87
0.52
35.6
12.8
—
—
—
0
0
(3022621) pH of Urine by Test strip
25
199
1.27
0.49
2.8
2.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
12
166
0.71
0.49
1.2
1.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
97
880
1.14
0.48
5.4
4.0
mg/mmol
30.4
9.5
0.93
75
543
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
282
2722
1.13
0.47
5.5
4.5
mu/l
2.1
2.4
0.29
264
2452
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
199
1885
1.11
0.47
3.7
3.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
5
84
0.59
0.46
1.2
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
5
84
0.59
0.46
1.2
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
5
84
0.59
0.46
1.2
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
5
84
0.59
0.46
1.2
1.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
7
50
1.41
0.45
1.0
1.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
5
31
1.62
0.43
1.0
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
6
91
0.65
0.43
1.2
1.5
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
267
2759
0.90
0.42
4.1
3.9
mmol/l
1.4
1.3
2.52
252
2511
(40768806) Pleura Pathology biopsy report
5
33
1.52
0.41
1.4
1.8
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
5
33
1.52
0.41
1.0
1.5
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
33
1.52
0.41
1.0
1.0
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
6.3
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
6.7
—
0.6
—
0
16
(40761536) Microorganisms panel - Urine sediment
31
260
1.21
0.41
4.9
3.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
8
61
1.32
0.39
1.3
1.3
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
10
72
1.40
0.37
1.2
1.4
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
5
78
0.64
0.36
3.8
3.7
mg/l
23.4
30.2
—
5
47
(3033705) Calcium.ionized [Moles/volume] in Venous blood
6
43
1.40
0.35
2.3
2.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
19
156
1.23
0.31
1.8
1.7
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
10
75
1.34
0.30
1.0
1.1
—
15.1
—
0
7
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
12
152
0.78
0.30
3.0
1.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
7
57
1.23
0.29
1.3
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
60
552
1.10
0.25
1.5
1.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
74
1.22
0.25
1.2
1.1
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
20
171
1.18
0.23
3.4
2.6
e6/l
0.3
0.2
0.29
20
165
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
101
1065
0.93
0.23
5.1
5.1
ug/l
3.8
3.0
0.17
91
942
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
39
1.29
0.23
1.2
1.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
5
42
1.19
0.21
2.0
1.5
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.1
—
151.2
—
0
11
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
5
43
1.16
0.21
1.2
1.1
—
14.4
—
0
9
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
0
13
0.00
0.21
0.0
1.2
—
1.2
—
0
5
(3037556) Urate [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3019977) pH of Arterial blood
0
14
0.00
0.20
0.0
2.9
—
7.4
—
0
5
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
81
855
0.93
0.19
4.5
4.4
%
20.7
21.6
0.24
42
424
(3019150) Specific gravity of Urine by Refractometry
70
659
1.08
0.19
6.2
4.0
kg/l
1.0
1.0
0.85
12
98
(3028707) Methadone [Presence] in Urine by Screen method
7
58
1.21
0.18
1.3
1.5
—
—
—
0
0
(4094501)
7
60
1.17
0.18
1.0
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
18
157
1.15
0.17
2.3
1.4
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
5
67
0.74
0.17
1.2
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
8
71
1.13
0.16
1.3
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
11
93
1.19
0.14
10.5
4.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
18
161
1.12
0.13
1.1
1.0
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
10
86
1.17
0.11
1.8
1.8
—
—
—
0
0
(4010399)
24
222
1.09
0.10
1.4
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
12
106
1.14
0.10
1.3
1.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
118
1155
1.03
0.08
6.2
3.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
39
372
1.05
0.08
26.5
7.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
12
133
0.90
0.08
1.3
1.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
84
819
1.03
0.07
5.9
3.8
estimate
0.0
0.0
0.50
31
278
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
64
624
1.03
0.05
2.9
3.0
ug/l
0.9
0.8
0.12
48
415
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
40
414
0.96
0.05
1.4
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
13
120
1.09
0.05
1.2
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
14
132
1.06
0.02
1.4
1.3
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
20
206
0.97
0.00
2.4
2.4
—
15.0
—
0
7
(3028300) Cannabinoids [Presence] in Urine
13
132
0.98
0.00
1.3
1.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
11
111
0.99
0.00
1.4
1.7
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
13
131
0.99
0.00
1.4
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
13
131
0.99
0.00
1.3
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
84
842
1.00
0.00
5.5
3.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
276
2762
1.00
0.00
37.9
13.0
ml/min/173m2
76.7
80.5
1.40
254
2267
(3009542) Hematocrit [Volume Fraction] of Blood
274
2738
1.00
0.00
55.2
14.8
%
35.1
39.8
13.56
191
1957
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
29
293
0.99
0.00
1.3
1.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
10
104
0.96
0.00
1.3
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
20
196
1.02
0.00
2.3
1.8
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
8
86
0.93
0.00
1.8
1.6
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
7
0.00
0.00
0.0
4.3
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
8
0.00
0.00
0.0
3.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.5
—
19.0
—
0
6
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
92.2
—
0
5
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
6
0.00
0.00
0.0
8.2
—
—
—
0
0
(3006598) pH of Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(4133840)
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(4034850)
9
99
0.91
0.00
18.4
9.8
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
6
64
0.94
0.00
1.3
1.4
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
8
0.00
0.00
0.0
3.1
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
6
67
0.89
0.00
1.8
1.5
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
7
69
1.01
0.00
1.1
1.6
—
—
—
0
0
(3004959) Base excess in Arterial cord blood by calculation
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806071)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
6
63
0.95
0.00
2.2
1.7
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint D3_OTHERAPLASTICANAEMIA and mortality.

Females

Parameter HR [95% CI] p-value
D3_OTHERAPLASTICANAEMIA 4.14 [3.24, 5.29] < 0.001
Birth year 0.995 [0.99, 1.0] 0.266

During the follow-up period (1.1.1998 — 31.12.2019), 646 out of 1166 females with D3_OTHERAPLASTICANAEMIA died.

Males

Parameter HR [95% CI] p-value
D3_OTHERAPLASTICANAEMIA 3.95 [3.02, 5.16] < 0.001
Birth year 0.991 [0.98, 1.0] 0.051

During the follow-up period (1.1.1998 — 31.12.2019), 660 out of 1238 males with D3_OTHERAPLASTICANAEMIA died.

Mortality risk

Mortality risk for people of age

years, who have D3_OTHERAPLASTICANAEMIA.

N-year risk Females Males
1 0.339% 0.703%
5 2.533% 4.934%
10 5.664% 12.691%
15 10.663% 22.855%
20 18.979% 36.188%

Relationships between endpoints

↥

Index endpoint: D3_OTHERAPLASTICANAEMIA – Other and unspecified aplastic anaemias

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data